EGFR and central nervous system cancer: There have been studies on the targeted delivery of mTORC1/mTORC2 inhibitor-loaded liposomes to glioma cells or elongated survival after a treatment consisting of photodynamic therapy (PDT) and liposomes encapsulating lapatinib (an EGFR inhibitor) in glioma-bearing rats [69,70].